The cancer-testis gene, NY-ESO-1, is expressed in normal fetal and adult testes and in spermatocytic seminomas and testicular carcinoma in situ
about
sameAs
HCA587 antigen expression in normal tissues and cancers: correlation with tumor differentiation in hepatocellular carcinomaCancer/testis antigens and gametogenesis: a review and "brain-storming" sessionDifferential expression of PRAMEL1, a cancer/testis antigen, during spermatogenesis in the mouseExpression of cancer-testis (CT) antigens in placenta.MAGE-A10 is a nuclear protein frequently expressed in high percentages of tumor cells in lung, skin and urothelial malignancies.Natural history of seminiferous tubule degeneration in Klinefelter syndrome.Developmental model for the pathogenesis of testicular carcinoma in situ: genetic and environmental aspects.Cancer/testis (CT) antigens are expressed in fetal ovary.Testis conserving chemotherapy in germ cell cancer: its potential to increase understanding of the biology and treatment of carcinoma-in-situ.The testicular germ cell tumour genome.The emerging phenotype of the testicular carcinoma in situ germ cell.Ovarian dysgerminomas are characterised by frequent KIT mutations and abundant expression of pluripotency markersCancer/testis (CT) antigens, carcinogenesis and spermatogenesis.Pathology of germ cell tumors of the testis.Microinvasive germ cell tumor of the testis.Directions in the immune targeting of cancer: lessons learned from the cancer-testis Ag NY-ESO-1.Spermatocytic seminoma: a 21 years' retrospective study in a tertiary care hospital in PakistanExpression profile of SPACA5/Spaca5 in spermatogenesis and transitional cell carcinoma of the bladder.Spermatocytic seminoma: review of the literature and description of a new case of the anaplastic variant.Human spermatogonial stem cells: a possible origin for spermatocytic seminoma.Testicular germ cell tumours in dogs are predominantly of spermatocytic seminoma type and are frequently associated with somatic cell tumours.New York esophageal squamous cell carcinoma-1 and cancer immunotherapy.Current status of engineered T-cell therapy for synovial sarcoma.MAGE-A9 mRNA and protein expression in bladder cancer.Spontaneous CD4+ and CD8+ T-cell responses directed against cancer testis antigens are present in the peripheral blood of testicular cancer patientsGiant Sertoli cell nodule of the testis: distinction from other Sertoli cell lesions.Chromosome X-encoded Cancer/Testis antigens are less frequently expressed in non-seminomatous germ cell tumors than in seminomas.Distinct expression patterns of the immunogenic differentiation antigen NY-BR-1 in normal breast, testis and their malignant counterparts.New evidence for the origin of intracranial germ cell tumours from primordial germ cells: expression of pluripotency and cell differentiation markers.Cancer testis antigen expression in testicular germ cell tumors and in intratubular germ cell neoplasia.Cancer/testis antigen expression and specific cytotoxic T lymphocyte responses in non small cell lung cancer.NY-ESO-1 Based Immunotherapy of Cancer: Current Perspectives.
P2860
Q24315946-2103845D-5811-4C6F-8E6D-2728EE406843Q24798047-63E3F48D-D98B-4986-BB8C-495999293AE9Q28587770-7D24FFD2-25E0-49F0-A4B8-30E2145CAA3EQ34111764-27B6E4A8-B79B-4243-B602-1D85B4AE32F1Q34196069-DB61F390-4CF3-41D5-A1B8-E09A94B260A6Q34452169-4CE0C6D0-DE82-4823-9693-623B15C964B1Q34502475-DF1F50D5-E4AA-4D17-BBA6-B55E76028632Q34797637-97EEC23E-F436-4987-91BE-D399EEF7F8E0Q35129471-D5C79C1A-2B78-4886-870A-9C13DB7C568CQ35129484-9F80B956-EB0A-4011-89F5-7EEAD08DB6C5Q35129514-C1273F37-9789-47BB-AFCB-FB690B8D67C5Q35634176-8B29842D-5F32-4952-B8D5-E4C826D4D51AQ35733359-D784A937-4AAD-46B8-84FE-FF58130334BAQ35996493-099949B8-6419-480F-BD0E-F733BBC17455Q36169443-E751489B-6D35-4116-9F6F-41E3BF10E7AAQ36471827-DE087864-415C-414A-A325-4077E28C5306Q37277740-D906CE20-39E8-409E-B0C6-9F564B1455BDQ37407149-7F240CE4-C6A3-4E7F-918C-2902473D4E8BQ37810696-CF028D6B-CE0F-4E93-8679-6BB731A53541Q37905877-D55FCBF8-A379-4C28-81DB-399AE331D069Q38410131-8DDCA11D-E54E-42CB-A30A-145C58674D38Q38445350-3566241C-C021-4A47-88E9-C783C041CF50Q38916522-B7297C8D-025B-48D9-95D0-28814BFBD5C8Q40172793-351D6129-8816-443B-9F0F-DBD79925C66DQ41077105-AD69ADEB-452F-45E0-8055-EA155EE49CCAQ41790711-EBBBF7D8-BF09-499E-860D-14AEAD0F1C1BQ43077451-84992CCC-2F1E-43BB-9090-D22B03304C2AQ46880106-5EBF1A58-F0FA-4393-825F-451E0BD90454Q48663779-8F19ED6B-92F2-4AB6-9BB4-7DC88742181EQ53220055-F0F94CB6-8227-4D21-86DA-94F75D6E2F27Q54574332-344BBCDB-A28E-4179-B19A-A5D7511D81B5Q54945263-173B6B73-48DB-4CCA-840A-6F709F25041D
P2860
The cancer-testis gene, NY-ESO-1, is expressed in normal fetal and adult testes and in spermatocytic seminomas and testicular carcinoma in situ
description
2002 nî lūn-bûn
@nan
2002 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
The cancer-testis gene, NY-ESO ...... d testicular carcinoma in situ
@ast
The cancer-testis gene, NY-ESO ...... d testicular carcinoma in situ
@en
The cancer-testis gene, NY-ESO ...... d testicular carcinoma in situ
@nl
type
label
The cancer-testis gene, NY-ESO ...... d testicular carcinoma in situ
@ast
The cancer-testis gene, NY-ESO ...... d testicular carcinoma in situ
@en
The cancer-testis gene, NY-ESO ...... d testicular carcinoma in situ
@nl
prefLabel
The cancer-testis gene, NY-ESO ...... d testicular carcinoma in situ
@ast
The cancer-testis gene, NY-ESO ...... d testicular carcinoma in situ
@en
The cancer-testis gene, NY-ESO ...... d testicular carcinoma in situ
@nl
P2093
P2860
P50
P3181
P1476
The cancer-testis gene, NY-ESO ...... d testicular carcinoma in situ
@en
P2093
Anne-Pascale Satie
Bernard Jégou
Giulio C Spagnoli
Grete Krag Jacobsen
Laurence Olivo
Michel Samson
Sébastien Henno
P2860
P304
P3181
P356
10.1097/01.LAB.0000017169.26718.5F
P407
P577
2002-06-01T00:00:00Z
P5875
P6179
1049180851